News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Inna D'Empaire, MD

Articles by Inna D'Empaire, MD

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
Published: February 3rd 2025 | Updated:

Trending on Psychiatric Times

FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of Narcolepsy Type 1

Zervimesine May Slow Progression of Dementia With Lewy Bodies, Phase 2 Results Show

The Winners of the Hanusol Contest for Peace: Ben Scherban, MD, and Kenneth Fung, MD

From Approval to Practice: How Has Cobenfy’s New Mechanism of Action Impacted Psychiatry?

Human Kindness Is a Key Advantage in Our Competition With Chatbot Therapists